Prosight Management’s Athenahealth, Inc. ATHN Stock Holding History

Prosight Management’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-41,193	Closed	-$6.55M	–	43
2018 Q2	$6.55M	Buy	+41,193	New	+$6.11M	4.81%	6

Other funds holding ATHN

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Prosight Management's ATHN Position: Q3 2018 in Review

Prosight Management sold out of Athenahealth, Inc. (ATHN) in Q3 2018, closing a stake of 41,193 shares — an estimated $6.55M sold.

Prosight Management first reported a position in ATHN in Q2 2018 and held it in 1 quarter. The position peaked at $6.55M in Q2 2018. 276 funds tracked by Wall St. Rank hold ATHN as of Q3 2018.

Prosight Management reported no remaining Athenahealth, Inc. position as of Q3 2018 after selling out during the quarter.
Prosight Management sold 41,193 Athenahealth, Inc. shares in Q3 2018, an estimated $6.55M.
Prosight Management first reported a position in Athenahealth, Inc. in Q2 2018 and held it in 1 quarter.
Prosight Management's Athenahealth, Inc. position peaked at $6.55M in Q2 2018.
276 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q3 2018.

Based on Prosight Management's 13F filing for Q3 2018, filed 15 Nov 2018.